Navigation Links
Posit Science Co-Founder and Brain Plasticity Pioneer, Michael Merzenich, Speaks at Science Conference in the Netherlands
Date:12/10/2008

AMSTERDAM, Netherlands, Dec. 10 /PRNewswire/ -- Michael Merzenich, PhD, a leading research scientist at the University of California and the Chief Scientist of Posit Science Corporation, gave the plenary lecture today at the opening ceremony of a joint conference of the Netherlands Institute for Neuroscience and the Royal Netherlands Academy of Arts and Science in Amsterdam. His talk, entitled "Cortical Plasticity-Based Therapeutics," presented evidence that neuroplasticity-based training can be a new kind of therapeutic tool used to address a wide variety of conditions from healthy aging to mental illness to dementia to brain injury.

Dr. Merzenich's company, Posit Science, translates the latest breakthroughs in neuroscience into cognitive training software that improves lives. The company's technology has been validated in many randomized controlled trials, and researchers have reported in more than 30 peer-reviewed articles in science and medical journals on numerous benefits, including: more than a doubling of processing speed; gains in memory and other cognitive functions equivalent to more than 10 years; improvements in activities correlated to maintaining independence; lower risk of serious decline in health related quality of life; better driving abilities and lower crash risk.

The Brain Fitness Program Classic(TM) was introduced by Posit Science in 2006 to improve auditory processing and memory. InSight(TM) was introduced by the company this year to improve visual processing and memory. Both programs are available from the company's website www.positscience.com.

The three day conference commemorates the 200th anniversary of the Royal Netherlands Academy of Arts and Science. Dr Merzenich will moderate all panel discussions tomorrow.

Dr. Merzenich is Professor Emeritus at the University of California, San Francisco, where he maintains a research lab and is a member of the National Academy of Sciences and of the Institute of Medicine. His discoveries have led to numerous inventions and have helped to revolutionize how scientists think about the brain.

About Posit Science:

Posit Science is the leading provider of clinically validated brain fitness programs. The company works with more than 50 scientists from prestigious universities to design and test its computer-based programs. More than 30 published papers show that in randomized controlled trials the company's patented technologies significantly increase processing speed, improve memory and attention, and enhance the quality of everyday life. Posit Science has received grants from the National Institutes of Health and has received numerous awards and accolades. The company's products, scientists and science are currently featured in the PBS documentaries "The Brain Fitness Program" and "Brain Fitness 2: Sight and Sound." For more information, visit http://www.PositScience.com or call 1-866-599-6463.


'/>"/>
SOURCE Posit Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Positively Conscious: An Enlightened Look At Life
2. Long Term Care Sector Supports and Is Well-Positioned to Advance Health Care Reform, Bolster Economic Stimulus
3. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
4. American Academy of Dermatology Issues Position Statement on Vitamin D
5. MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
6. Largest study of fertility patients shows concerns about embryo disposition
7. Posit Science Featured in Canadian Documentary on the Brain
8. Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions
9. Opposition Continues to Grow to Blues Legislation
10. European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1
11. BET Networks Joins the International Call to Stop the Spread of HIV on World AIDS Day Monday, December 1 with a Special Episode of 106 & PARK Followed by BET News Exclusive ARE YOU POSITIVE?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May 20 and ... educational and exciting 2-day program. , An attendee at a recent PAINWeekEnd said, ... patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to using ... Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 years, ... USA, and former member of the American Association of Christian Counselors. Rachel studied ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke ... its ANCD BRAIN device as the product advances towards regulatory and clinical phases. ...
(Date:4/22/2017)... (PRWEB) , ... April 22, ... ... Administration of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its ... Heron-Doerr, PROSHRED® Philadelphia specializes in providing information destruction , recycling, ...
(Date:4/21/2017)... ... 2017 , ... Providing broad access to life-saving drugs and rewarding the innovators ... way to address this problem. , That was the message from Dana Goldman, PhD, ... the University of Southern California, who served as the keynote speaker for Western University ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/18/2017)... April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and providing ... is in conjunction with this morning,s announcement of the ... and Nutritional Insufficiency businesses. Cardinal Health now ... will be at the bottom of its previous guidance ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and ... today announced the signing of a three-year exclusive ... will deploy a dedicated sales team to introduce ... U.S., primarily focused in 13 states in the ...
Breaking Medicine Technology: